Mathematical modeling of atopic dermatitis reveals “double‐switch” mechanisms underlying 4 common disease phenotypes
暂无分享,去创建一个
Mariko Okada-Hatakeyama | Elisa Domínguez-Hüttinger | Masato Kubo | Panayiotis Christodoulides | M. Kubo | Elisa Domínguez-Hüttinger | A. Irvine | Kosuke Miyauchi | Alan D Irvine | Reiko J Tanaka | Kosuke Miyauchi | R. Tanaka | Panayiotis Christodoulides | M. Okada‐Hatakeyama
[1] W. Paul,et al. Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment , 2005, The Journal of experimental medicine.
[2] S. Akira,et al. Keratinocyte‐specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis , 1999, The EMBO journal.
[3] S. Wakana,et al. Hyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis. , 2016, The Journal of clinical investigation.
[4] S. Feldman,et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. , 2014, Journal of the American Academy of Dermatology.
[5] Stephen J. Galli,et al. The development of allergic inflammation , 2008, Nature.
[6] L. Beck,et al. Innate immune defects in atopic dermatitis. , 2006, The Journal of allergy and clinical immunology.
[7] P. Ahmad-Nejad,et al. The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. , 2004, The Journal of allergy and clinical immunology.
[8] D. Koenig,et al. Immediate and extended effects of sodium lauryl sulphate exposure on stratum corneum natural moisturizing factor , 2014, International journal of cosmetic science.
[9] Thomas B. Clarke,et al. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. , 2009, The Journal of clinical investigation.
[10] Manuel A. R. Ferreira,et al. Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis , 2015, Nature Genetics.
[11] A. Wollenberg,et al. Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema , 2012, Annals of dermatology.
[12] D. Koenig,et al. Immediate and extended effects of abrasion on stratum corneum natural moisturizing factor , 2015, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.
[13] Prabir Ray,et al. A critical role for NF-κB in Gata3 expression and TH2 differentiation in allergic airway inflammation , 2001, Nature Immunology.
[14] H. Dommisch,et al. Protease-Activated Receptor 2 Mediates Human Beta-Defensin 2 and CC Chemokine Ligand 20 mRNA Expression in Response to Proteases Secreted by Porphyromonas gingivalis , 2007, Infection and Immunity.
[15] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[16] M. Akiyama,et al. Clinical severity correlates with impaired barrier in filaggrin-related eczema. , 2009, The Journal of investigative dermatology.
[17] M. Ono,et al. Skin Barrier Homeostasis in Atopic Dermatitis: Feedback Regulation of Kallikrein Activity , 2011, PloS one.
[18] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[19] Stephan Weidinger,et al. Atopic dermatitis , 2016, The Lancet.
[20] T. Jean,et al. Variability In Measurement Of Allergen Skin Testing Results Among Allergy-Immunology Specialists , 2014 .
[21] A. Irvine,et al. Filaggrin mutations associated with skin and allergic diseases. , 2011, The New England journal of medicine.
[22] A. Borkowski,et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. , 2011, The Journal of investigative dermatology.
[23] R. Tazi-Ahnini,et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. , 2006, The Journal of allergy and clinical immunology.
[24] A. Irvine,et al. The multifunctional role of filaggrin in allergic skin disease. , 2013, The Journal of allergy and clinical immunology.
[25] Kazuyuki Aihara,et al. Hybrid optimal scheduling for intermittent androgen suppression of prostate cancer. , 2010, Chaos.
[26] P. Dubus,et al. Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome , 2009, The Journal of experimental medicine.
[27] K. Barnes,et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. , 2007, The Journal of allergy and clinical immunology.
[28] K. Cease,et al. Staphylococcus δ-toxin induces allergic skin disease by activating mast cells , 2013, Nature.
[29] Masahiro Ono,et al. Skin disease modeling from a mathematical perspective. , 2013, The Journal of investigative dermatology.
[30] M. Cork,et al. The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis , 2014, The British journal of dermatology.
[31] K. Asadullah,et al. Glucocorticoid therapy‐induced skin atrophy , 2006, Experimental dermatology.
[32] K. Nakanishi,et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice , 2013, Proceedings of the National Academy of Sciences.
[33] C. Gieger,et al. Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects , 2013, The Journal of allergy and clinical immunology.
[35] G. Imokawa,et al. Reevaluation of the non-lesional dry skin in atopic dermatitis by acute barrier disruption: an abnormal permeability barrier homeostasis with defective processing to generate ceramide , 2014, Archives of Dermatological Research.
[36] Matias Ostrowski,et al. Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions , 2014, Front. Immunol..
[37] P. Fallon,et al. Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis , 2015, Front. Immunol..
[38] Colin N A Palmer,et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis , 2006, Nature Genetics.
[39] A. Taïeb,et al. Biologics in atopic dermatitis , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[40] A. Shiohama,et al. A homozygous frameshift mutation in the murine filaggrin gene facilitates enhanced percutaneous allergen priming , 2009, Nature Genetics.
[41] Diego A Oyarzún,et al. Multistability and oscillations in genetic control of metabolism. , 2012, Journal of theoretical biology.
[42] T. Ganz,et al. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. , 2008, The Journal of investigative dermatology.
[43] D. Ioannides,et al. Investigation of cytokine levels and their association with SCORAD index in adults with acute atopic dermatitis , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.
[44] Bodo Grimbacher,et al. STAT3 mutations in the hyper-IgE syndrome. , 2007, The New England journal of medicine.
[45] A. Buret,et al. PAR2 activation alters colonic paracellular permeability in mice via IFN‐γ‐dependent and ‐independent pathways , 2004, The Journal of physiology.
[46] R. Gallo,et al. The Role of the Skin Microbiome in Atopic Dermatitis , 2015, Current Allergy and Asthma Reports.
[47] S. Kežić,et al. Intragenic Copy Number Variation within Filaggrin Contributes to the Risk of Atopic Dermatitis with a Dose-Dependent Effect , 2011, The Journal of investigative dermatology.
[48] Min Chen,et al. Regulation of the lifespan in dendritic cell subsets. , 2007, Molecular immunology.
[49] Kenneth R Feingold,et al. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. , 2003, The Journal of investigative dermatology.
[50] P. Elias,et al. Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis. , 2014, The Journal of allergy and clinical immunology.
[51] M. Suárez-Fariñas,et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. , 2012, The Journal of allergy and clinical immunology.
[52] Grant Lythe,et al. How many dendritic cells are required to initiate a T-cell response? , 2012, Blood.
[53] R. Unger,et al. Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT , 2014, Bone Marrow Transplantation.
[54] S. Kežić,et al. Atopic dermatitis and skin disease Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency , 2012 .
[55] S. Akira,et al. Enhanced apoptosis by disruption of the STAT3-IκB-ζ signaling pathway in epithelial cells induces Sjögren's syndrome-like autoimmune disease. , 2013, Immunity.
[56] H. Williams,et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention , 2014, The Journal of allergy and clinical immunology.
[57] Thomas Bieber,et al. Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful? , 2014, The Journal of allergy and clinical immunology.
[58] D. Leung,et al. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. , 2014, The Journal of allergy and clinical immunology.
[59] A. Schmidtchen,et al. Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin‐associated microbial antigens in adult patients with atopic dermatitis , 2014, International journal of dermatology.
[60] P. Elias,et al. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. , 2008, The Journal of investigative dermatology.
[61] J. Spergel. Epidemiology of atopic dermatitis and atopic march in children. , 2010, Immunology and allergy clinics of North America.
[62] Reiko J. Tanaka,et al. Resistance to Water Diffusion in the Stratum Corneum Is Depth-Dependent , 2015, PloS one.
[63] Richard A Flavell,et al. The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells , 1997, Cell.
[64] Julia Oh,et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis , 2012, Genome research.
[65] Mauricio Barahona,et al. Risk factor-dependent dynamics of atopic dermatitis: modelling multi-scale regulation of epithelium homeostasis , 2013, Interface Focus.
[66] H. Wong,et al. The role of the skin barrier in modulating the effects of common skin microbial species on the inflammation, differentiation and proliferation status of epidermal keratinocytes , 2013, BMC Research Notes.
[67] F. Chew,et al. Global Allergy Forum and 3rd Davos Declaration 2015 , 2016, Allergy.
[68] H. Mizuno,et al. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. , 2012, The Journal of allergy and clinical immunology.
[69] Kazuyuki Aihara,et al. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers , 2012, Scientific Reports.
[70] Takashi Sasaki,et al. Application of moisturizer to neonates prevents development of atopic dermatitis. , 2014, The Journal of allergy and clinical immunology.
[71] J. Sundberg,et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. , 2009, The Journal of allergy and clinical immunology.
[72] Andreas Radbruch,et al. GATA-3 transcriptional imprinting in Th2 lymphocytes: A mathematical model , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[73] Kumiko Morita. Application of moisturizer to neonates prevents development of atopic dermatitis , 2015, The World Allergy Organization Journal.